| 1/6 | US=8 / Laboratório Lecker SH, Saric T, Goldberg AL. Protein degradation in cells. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 34-41. ISBN 978-0-443-06715-0. DEGRADACAO DE PROTEINAS; PROTEOLISE LISOSSOMAL; CONJUGACAO DA UBIQUITINA; INIBIDORES DE PROTEASSOMA; TERAPIA DO CANCER; DEGRADACAO ASSOCIADA AO RETICULO ENDOPLASMATICO; PROTEOLISE EM MITOCONDRIA; QUEBRA DE PROTEINA MUSCULAR; CAQUEXIA |
| 2/6 | US=85 / Biol/Mol Plantivaux A, Szegezdi E, Samali A, Egan L. Is there a role for nuclear factor kB in tumor necrosis factor-related apoptosis-inducing ligand resistance?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 38-49. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. CANCER; APOPTOSE; RESISTENCIA; INIBIDORES DE PROTEASSOMA; SUPER-REPRESSOR; MTOR; TRAIL; NF-KB |
| 3/6 | US=15 / Gastro El-Rayes B. An overview of clinical trials of targeted therapies in pancreatic cancer. In: Lowy AM, Leach SD, Philip PA. Pancreatic cancer. New York: Springer, 2008. p. 565-75. ISBN 978-0-387-69250-0. TERAPIAS-ALVO. CANCER DE PANCREAS; INIBIDORES DE PROTEASSOMA; INIBIDORES DA ANGIOGENESE; RAS INIBIDORES |
| 4/6 | US=80 / Biol/Mol Gjertsen BT, Sjoholt G. Proteomic strategies of therapeutic individualization and target discovery in acute myeloid leukemia. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 161-87. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. LEUCEMIA MIELOIDE AGUDA; BIOMARCADORES; PHARMACOPROTEOMICS; ACIDO TRANS-RETINOICO; INIBIDORES DE QUINASE DE TIROSINA; HISTONA DEACETILASE INIBIDORES; INIBIDORES DE PROTEASSOMA |
| 5/6 | US=8 / Quimioterapia O'Connor OA. Proteasome inhibitors. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 621-40. ISBN 978-0-7817-5628-6. INIBIDORES DE PROTEASSOMA; QUIMICA; MECANISMOS DE ACAO; FARMACOLOGIA |
| 6/6 | US=22-C / Câncer Kirk CJ, Tuch BB, Arastu-Kapur S, Boise LH. Inibidores de proteassoma. In: DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 10 ed. Philadelphia: Wolters Kluwer, 2015. p. 258-262. ISBN 978-1-45119294-0. VIA DA UBIQUITINA PROTEOSSOMA. BIOQUIMICA; CLASSES QUIMICAS DE INIBIDORES DE PROTEASSOMA EM DESENVOLVIMENTO CLINICO; ATIVIDADE PRE-CLINICOS DE INIBIDORES DE PROTEASSOMA; INIBIDORES DE PROTEASSOMA EM CANCER; BIOMARCADORES DE INIBIDORES DE PROTEASSOMA |